Smarthealth Incorporated v. Chemotechnique MB Diagnostics AB, et al.

CourtDistrict Court, D. Arizona
DecidedDecember 9, 2025
Docket2:25-cv-00115
StatusUnknown

This text of Smarthealth Incorporated v. Chemotechnique MB Diagnostics AB, et al. (Smarthealth Incorporated v. Chemotechnique MB Diagnostics AB, et al.) is published on Counsel Stack Legal Research, covering District Court, D. Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Smarthealth Incorporated v. Chemotechnique MB Diagnostics AB, et al., (D. Ariz. 2025).

Opinion

1 WO 2 3 4 5 6 IN THE UNITED STATES DISTRICT COURT 7 FOR THE DISTRICT OF ARIZONA

9 Smarthealth Incorporated, No. CV-25-00115-PHX-JJT

10 Plaintiff, ORDER

11 v.

12 Chemotechnique MB Diagnostics AB, et al.,

13 Defendants.

14 At issue is Plaintiff Smarthealth Incorporated’s Motion for Leave to File Sur-Reply 15 (Doc. 52). For the reasons set forth below, the Court will grant Plaintiff’s Motion and will 16 permit Defendant Chemotechnique MB Diagnostics AB to file its own sur-reply. 17 “Indeed, sur-replies are highly disfavored and permitted only in extraordinary 18 circumstances.” Burgess v. Shinn, No. CV-21-01164-PHX-DJH, 2022 U.S. Dist. LEXIS 19 115200, at *3 (D. Ariz. June 28, 2022) (citation modified). “The Court may, in its 20 discretion, permit a party to file a sur-reply, considering whether the movant’s reply in fact 21 raises arguments or issues for the first time, whether the nonmovant’s proposed sur-reply 22 would be helpful to the resolution of the pending motion, and whether the movant would 23 be unduly prejudiced were leave to be granted.” Cattanach v. Maricopa Cty. Cmty. Coll. 24 Dist., No. CV-22-00572-TUC-RCC, 2023 U.S. Dist. LEXIS 55353, at *1–2 (D. Ariz. Mar. 25 29, 2023) (citation modified). 26 Defendant moves to dismiss Plaintiff’s claims for lack of personal jurisdiction. (See 27 Doc. 12.) Courts in the Ninth Circuit use a tripartite test to determine whether a nonresident 28 defendant’s minimum contacts with the forum pass constitutional muster for specific 1 jurisdiction to exist. As relevant here, the parties fully briefed the first element of the 2 minimum contacts test. 3 The second element of the minimum contacts test requires Plaintiff to establish that 4 its claim “arises out of or relates to the defendant’s forum-related activities.” Morrill v. 5 Scott Fin. Corp., 873 F.3d 1136, 1142 (9th Cir. 2017). Defendant’s Motion to Dismiss 6 features no exploration of this element. Instead, it merely concludes that if Plaintiff “cannot 7 meet the [first element], it cannot meet this element, either.” (Doc. 12 at 12.) In response, 8 Plaintiff asserts the inverse of Defendant’s argument: that Plaintiff meets the second 9 element because it meets the first. (Doc. 45 at 15–16.) Neither conclusory statement aids 10 the Court in applying the second element standards to the complex jurisdictional facts of 11 this case. See, e.g., Ford Motor Co. v. Mont. Eighth Judicial Dist. Court, 592 U.S. 351, 12 362 (2021) (analyzing the “arises out of” standard of the second element); Yamashita v. 13 LG Chem, Ltd., 62 F.4th 496, 505 (9th Cir. 2023) (analyzing the “relates to” standard of 14 the second element). 15 The third element of the minimum contacts test requires Defendant to refute the 16 reasonableness of exercising specific jurisdiction over it. Morrill, 873 F.3d at 1142. 17 Defendant made no effort to do so in its Motion to Dismiss, and Plaintiff devoted one single 18 paragraph to rebut its best estimation of Defendant’s unrevealed arguments. (Doc. 45 at 19 16–17.) 20 It was only until Defendant’s reply memorandum that either party meaningfully 21 grappled with the second element and Defendant attempted to meet its burden as to the 22 third element. (Doc. 51 at 4–11.) Plaintiff then filed its Motion for Leave, claiming that 23 Defendant raised new arguments for the first time in reply. (Doc. 52.) Defendant argues 24 that its Reply merely rebuts Plaintiff’s Response, and it is not Defendant’s burden to raise 25 and establish the second element. (Doc. 54 at 2.) 26 The arguments Defendant raised in reply are not new, but only in the most 27 superficial sense. It is true that Plaintiff did raise arguments about the second and third 28 elements in response—albeit only briefly. But Defendant’s Reply provided the first || account of its substantive arguments as to the second and third elements, and Plaintiff has || not had the opportunity to meaningfully counter that substance. Defendant’s contention 3 || that it had no responsibility for addressing the second or third element until it was raised by Plaintiff is also unpersuasive. While Plaintiff has the burden of meeting the second || element, Morrill, 873 F.3d at 1142, it is Defendant’s burden to meet the third element, id., 6|| and to ultimately persuade this Court to dismiss Plaintiff's claims as the moving party, 7\| Makah Indian Tribe v. Verity, 910 F.2d 555, 558 (9th Cir. 1990). 8 At this juncture, only the first element of the minimum contacts test is sufficiently 9|| developed before the Court. To assist the Court in resolving the pending Motion to Dismiss 10 || and to ensure each party has a full and fair opportunity to address opposing arguments, the 11 || Court will grant Plaintiff's leave to file its Sur-reply. Because Defendant carries “the || burden of persuasion in arguing for dismissal” as the moving party, id., the Court will also 13 || permit Defendant to file its own sur-reply. No later than seven days from the date of this Order, Defendant may file a sur-reply addressing only those arguments raised in □□□□□□□□□□□ 15 || Sur-Reply. 16 IT IS THEREFORE ORDERED granting Plaintiff Smarthealth, Inc.’s Motion for || Leave to File Sur-Reply (Doc. 52). 18 IT IS FURTHER ORDERED directing the Clerk of Court to file onto the public docket Plaintiff Smarthealth, Inc.’s Sur-Reply to Defendant Chemotechnique MB 20 || Diagnostics AB’s Reply Supporting Its Motion to Dismiss (Doc. 53). 21 IT IS FURTHER ORDERED that, no later than seven days from the date of this || Order, Defendant Chemotechnique MB Diagnostics AB may file a sur-reply addressing 23 || only those arguments raised in Plaintiff Smarthealth, Inc.’s Sur-Reply currently lodged at 24 || docket entry 53. 25 Dated this 8th day of December, 2025. CN 26 “wok: 97 wefehlee— Unifga State#District Judge 28

-3-

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Makah Indian Tribe v. C. William Verity
910 F.2d 555 (Ninth Circuit, 1990)
K. Morrill v. Scott Financial Corp.
873 F.3d 1136 (Ninth Circuit, 2017)
Ford Motor Co. v. Montana Eighth Judicial Dist.
592 U.S. 351 (Supreme Court, 2021)
Matt Yamashita v. Lg Chem, Ltd.
62 F.4th 496 (Ninth Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Smarthealth Incorporated v. Chemotechnique MB Diagnostics AB, et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/smarthealth-incorporated-v-chemotechnique-mb-diagnostics-ab-et-al-azd-2025.